Behind the Paper: Hepatitis B discrimination: global responses requiring global data

As we approach World Hepatitis Day on July 28 this year, it is important to bring awareness to hepatitis B, the need to work towards elimination and the impact hepatitis B has on those with lived experience.

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

BioMed Central
BioMed Central BioMed Central

Hepatitis B discrimination: global responses requiring global data - BMC Public Health

Over 250 million individuals live with chronic hepatitis B (CHB) infection worldwide. A significant proportion of these people often face discrimination defined as the unjust, unfair, or prejudicial treatment of a person on the grounds of their hepatitis B status. Hepatitis B related discrimination has not been widely documented in the literature. This study aims to describe the lived experience of discrimination, document its impact, and shed light on its consequences. A hepatitis B discrimination registry was launched to record self-reported discrimination associated with hepatitis B. The registry included brief demographic questions (age, gender, country of origin), discrimination-specific questions (where, when, and how discrimination occurred), and open-ended questions to detail specific experiences. The registry was distributed to hepatitis B patient/people-focused listservs, social media networks, and community-based organizations around the globe. Descriptive data were analyzed including comparative analysis by country and type of discrimination occurring along with qualitative data (open-ended responses) which were analyzed using thematic analysis techniques A total of 569 individuals responded to the survey between May 2021 and December 2023. Individuals identified as residing in the Philippines (34%; N = 194), Nigeria (11%; N = 60), Pakistan (8%; N = 45), India (6%, N = 34), Uganda (5%; N = 31), the United States of America (4%, N = 26), Ghana (3%; N = 15), Ethiopia (2%; N = 14), and other countries in smaller number with a total of 65 countries reported discrimination at least by one individual. Of these, 461 individuals shared details about their experiences of discrimination with most relating to restrictions on access to work visas, followed by in-country hepatitis B-related employment restrictions, educational-based discrimination, discrimination within the community and health facilities, and the emotional impact of hepatitis B discrimination. This is the largest primary collection of hepatitis B-associated discrimination events and highlights how hepatitis B discrimination clearly has a significant impact on individuals’ lives and limits economic opportunities regardless of physical symptoms. Such impacts likely act as barriers to diagnosis and engagement in care, so need to be addressed to achieve the global hepatitis B elimination goals. The data highlight a need for global, national responses and more systematic responses to discrimination experienced by people with hepatitis B.

Explore the research:

Over 250 million people worldwide live with chronic hepatitis B, yet most remain undiagnosed and at risk for liver disease. Improving testing, linkage to care, and access to treatment is essential to reduce the burden of hepatitis B and achieve global elimination goals. As countries continue efforts to improve diagnosis and care, it is equally important to understand the psychological and social consequences of a hepatitis B diagnosis—particularly the impact of stigma and discrimination.

Discrimination related to hepatitis B is defined as unjust, unfair, or prejudicial treatment based on a person’s hepatitis B status. Stigma, on the other hand, is a social process—either experienced or anticipated—characterized by exclusion, rejection, blame, or devaluation resulting from perceived or expected negative social judgment.

To better understand and document these issues, this study explores the lived experiences of people with hepatitis B around the world. It focuses on the types, contexts, settings, and locations of discrimination, as well as the impact such experiences have on individuals and efforts to eliminate hepatitis B.

What inspired this study?

The Hepatitis B Foundation operates a consultation line where individuals with lived experience, as well as their family members and caregivers, can ask questions and share their stories. Between 2019 and 2021, the Foundation began receiving a growing number of reports of discrimination from individuals living with hepatitis B.

To better understand and address these concerns, the Foundation conducted stakeholder interviews with key opinion leaders and experts in the field. Based on insights from these conversations, researchers recognized the need to document and track experiences of discrimination more systematically and to develop advocacy recommendations for change.

In May 2021, the Foundation launched a discrimination registry to provide individuals affected by hepatitis B–related discrimination with a platform to share their experiences and access support resources. This study presents findings and insights gathered from the registry to inform ongoing advocacy and support efforts.

Why is it important?

This study is the largest collection to date of hepatitis B–related discrimination experiences, revealing that such discrimination is a global issue occurring in employment, education, healthcare, and personal relationships. In countries like Saudi Arabia and Pakistan, premarital hepatitis B screening often results in rejected marriage prospects and social exclusion, underscoring how deeply rooted this stigma can be.

Many individuals reported being tested without consent and denied opportunities to work, study, or form relationships—leading to emotional distress, social isolation, and poorer health outcomes. Discrimination also creates economic barriers, forcing individuals to prioritize survival over care and treatment.

A major driver of this discrimination is a widespread lack of knowledge about hepatitis B, even among healthcare providers. Misinformation about transmission and disease progression fuels fear and stigma, highlighting the urgent need for education at both the community and professional levels.

While some countries have anti-discrimination policies, enforcement is inconsistent. As global testing efforts expand to meet hepatitis B elimination goals, there is a critical ethical need to ensure protective measures are in place.

This research underscores the need for stronger policies, education, and supportive services to protect people living with hepatitis B and help them lead full, healthy lives free from discrimination.

What makes this study unique?

This study is unique in that it captures lived experiences of hepatitis B–related discrimination from a global perspective. Patient-reported outcomes—particularly stigma and discrimination—are often overlooked in discussions about hepatitis B. Understanding these personal experiences is essential to developing effective protections, reducing the negative consequences of discrimination, and supporting those affected by the disease.

What is the wider significance of the study findings?

As we approach World Hepatitis Day this year (July 28, 2025), it is important to acknowledge the impact that hepatitis B has globally and account for programming that involves those with lived experience to improve outcomes. Efforts should prioritize mitigating the negative consequences associated with infection and work towards developing public health interventions that address stigma and discrimination including policy measures that prevent discrimination from occurring.

References:

Follow the Topic

Hepatitis B virus
Life Sciences > Biological Sciences > Microbiology > Virology > Hepatitis B virus
Public Health
Life Sciences > Health Sciences > Public Health
Global Health
Humanities and Social Sciences > Society > Sociology > Health, Medicine and Society > Global Health
Infectious Diseases
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Infectious Diseases

Related Collections

With Collections, you can get published faster and increase your visibility.

HIV stigma

BMC Public Health is calling for submissions to our Collection on HIV stigma, which remains a critical barrier to achieving optimal health outcomes for individuals living with HIV. Stigma undermines their quality of life, access to healthcare, and overall well-being. Despite significant advancements in treatment and prevention, discrimination and stigma continue to perpetuate fear, isolation, and misinformation within communities.

The urgency to address HIV stigma is heightened in the context of global health initiatives, as we strive for a more inclusive society where individuals living with HIV are empowered, well-informed, and treated with dignity. This Collection aims to gather cutting-edge research and diverse perspectives that illuminate the multifaceted nature of HIV stigma, highlighting the intersections of culture, policy, and public health that shape the experiences of those affected.

The Collection welcomes scholarship that not only documents stigma but also advances new ways of understanding and responding to it. We particularly invite work that examines stigma as a social, structural, and relational force that shapes care, rights, intimacy, and everyday life for people living with HIV.

The scope of this Collection encompasses a range of topics related to HIV stigma, including but not limited to:

  • Qualitative research that foregrounds the knowledge, agency, and perspectives of people living with HIV and others affected by stigma
  • Psychosocial dimensions of stigma experienced by people living with HIV
  • The role of HIV awareness campaigns in combating stigma
  • Innovative and community engaged approaches to measuring or addressing stigma
  • Policy analyses addressing stigma in healthcare settings
  • Intersectional analyses of stigma across gender, sexuality, age and migration, social, environmental or structural determinants of health contributing to discrimination
  • Impacts of digital spaces, media narratives, and global health governance on stigma

This Collection supports and amplifies research related to SDG 3: Good Health & Well-being and SDG 10: Reduced Inequalities. We strongly encourage submissions from the global south and from teams that include community partners and lived experience experts.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Dec 01, 2026

Digital exclusion and health equity

Digital exclusion poses significant barriers to health equity, particularly in the context of an increasingly technology-driven healthcare landscape. Many individuals, especially from underserved communities face challenges in accessing digital health resources, including telehealth services, electronic health records, and health information online, alongside challenges from other social determinants of health. This Collection seeks to explore the intersection of digital health access and health equity, focusing on the disparities that arise from unequal access to digital tools and resources.

Addressing digital health exclusion is critical for promoting health equity and ensuring that all individuals can benefit from advancements in digital health. Recent strides in telehealth and digital health interventions have demonstrated the potential for technology to improve access to care, yet they also reveal significant disparities that must be acknowledged. By understanding the factors that contribute to eHealth disparities, we can develop targeted digital inclusion strategies that address the unique needs of diverse populations, ultimately fostering a more equitable health system.

Topics for submission include but are not limited to:

  • Equitable digital health systems: policy, infrastructure, and community engagement
  • Digital health access among underserved communities
  • Digital literacy and health outcomes across diverse populations
  • Innovations and implementation strategies for bridging digital health gaps in underserved communities
  • Measuring and monitoring digital health disparities: metrics and methodologies

This Collection supports and amplifies research related to SDG 3 (Good Health and Well Being) and SDG 10: (Reduced Inequalities).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Dec 11, 2026